In this April 29, 2019, article from Reuters Health, Stacie Dusetzina, PhD, associate professor in the Department of Health Policy, explains why rising drug prices for neurological conditions like epilepsy and multiple sclerosis can create potentially riskier situations for patients and higher rates of emergency department use for hospitals.
Read the full report from Reuters Health here: https://www.reuters.com/article/us-health-neurology-drug-costs/patients-drug-costs-surge-for-some-neurologic-conditions-idUSKCN1S74P5